Article Text

Download PDFPDF
Audit, research and guideline update
Migration and tuberculosis in the UK: targeting screening for latent infection to those at greatest risk of disease
  1. Michelle E Kruijshaar1,2,
  2. Ibrahim Abubakar1,3,
  3. Helen R Stagg1,3,
  4. Debora Pedrazzoli1,
  5. Marc Lipman4
  1. 1Tuberculosis Section, Public Health England, London, UK
  2. 2Centre for Lysosomal and Metabolic Diseases, Sophia Children's Hospital, Erasmus MC University Medical Centre, Rotterdam, The Netherlands
  3. 3Research Department for Infections and Population Health, University College London, London, UK
  4. 4Centre for Respiratory Medicine, Royal Free London NHS Foundation Trust, University College London, London, UK
  1. Correspondence to Dr M E Kruijshaar, Centre for Lysosomal and Metabolic Diseases, Sophia Children's Hospital, Erasmus MC University Medical Centre, Dr Molenwaterplein 60, Rotterdam 3000 CB, The Netherlands; m.kruijshaar{at}erasmusmc.nl

Abstract

Active tuberculosis (TB) in the UK predominantly affects the non-UK born, but is generally not manifest at the time of UK entry. Strategies to detect latent TB infection (LTBI) in this population are, therefore, important. To date, targeted screening has focused on TB risk estimates based on the incidence in the country of origin. Using TB incidence in the UK and migration data, we estimated the numbers needed to be tested and treated for LTBI to prevent one case of TB disease. Numbers were the lowest in Somalian and the highest in South African and Filipino migrants, which contrasts with TB rates in these countries. Targeting screening on the basis of incidence in the UK may thus improve effectiveness.

  • Tuberculosis

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.